U.S. FDA approves Gilead triple HIV drug, rival files lawsuit

(Reuters) – The U.S. Food and Drug Administration on Wednesday approved Biktarvy, Gilead Sciences Inc’s once-daily, triple-combination tablet for treatment of HIV infection, paving the way for the biotech company to capture more of the multibillion-dollar HIV drug market.


Source: Reuters Medical News

Lawmakers ask FDA to reject Philip Morris' iQOS application

WASHINGTON/NEW DELHI (Reuters) – Ten U.S. senators called on the Food and Drug Administration to reject Philip Morris International Inc’s application to market its iQOS smoking device as being less risky than cigarettes, according to a letter to the agency’s commissioner.


Source: Reuters Medical News

Hong Kong schools to shut early due to flu outbreak

HONG KONG (Reuters) – Hong Kong authorities, grappling with a seasonal flu outbreak, have decided to shut all kindergartens and primary schools from Thursday, days ahead of scheduled Lunar New Year holidays, to rein in spread of the disease.


Source: Reuters Medical News